Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
bortezomib (velcade) (1 trial)
inactivated covid-19 vaccine (2 trials)
kw-2478 (1 trial)
Multiple Myeloma (Phase 2)
Neoplasms, Plasma Cell (Phase 2)
Trials (3 total)
Trial APIs (3 total)